Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients

Objective Disturbed endothelial function is closely associated with hyperinsulinaemia and insulin resistance in essential hypertension. The aims of this study were: 1) to evaluate whether the two alternative drugs, angiotensin-converting enzyme (ACE) inhibitors and Angiotensin II (Ang II) antagonist...

Full description

Bibliographic Details
Main Authors: Dilek Yavuz, Mehmet Koç, Ahmet Toprak, Ihsan Akpιnar, Ayliz Velioğlu, Oguzhan Deyneli, Goncagül Haklar, Sema Akalln
Format: Article
Language:English
Published: SAGE Publications 2003-09-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.3317/jraas.2003.032
_version_ 1797288991607750656
author Dilek Yavuz
Mehmet Koç
Ahmet Toprak
Ihsan Akpιnar
Ayliz Velioğlu
Oguzhan Deyneli
Goncagül Haklar
Sema Akalln
author_facet Dilek Yavuz
Mehmet Koç
Ahmet Toprak
Ihsan Akpιnar
Ayliz Velioğlu
Oguzhan Deyneli
Goncagül Haklar
Sema Akalln
author_sort Dilek Yavuz
collection DOAJ
description Objective Disturbed endothelial function is closely associated with hyperinsulinaemia and insulin resistance in essential hypertension. The aims of this study were: 1) to evaluate whether the two alternative drugs, angiotensin-converting enzyme (ACE) inhibitors and Angiotensin II (Ang II) antagonists, had comparable effects on glucose metabolism and endothelial function. 2) to determine whether they improve endothelial dysfunction through modulating insulin resistance and oxidative stress. Study design and methods Study design and methods Essential hypertensive patients were randomised into two groups: Twelve (nine patients in final analysis) patients were given enalapril (enalapril group), and twelve (nine patients in final analysis) were given losartan (losartan group). Twelve sex- and age-matched normotensive volunteers were included as controls. Before and after six months of treatment, endothelial function, insulin sensitivity and lipid peroxidation (TBARs) and NO metabolites (NOx) were evaluated. Results Endothelial function, measured as flow mediated dilatation (FMD), was improved in both of the treatment groups (p=0.0001). Calculated insulin sensitivity index also improved in the enalapril-treated group (p=0.05) but not in the losartan-treated group, compared with baseline levels. TBARS values decreased significantly in the enalapril group compared with baseline levels (p<0.001). FMD was positively correlated with insulin sensitivity index (r=0.32, p<0.05) and NOx levels (r=0.39, p=0.01) and negatively correlated with TBARS levels (r=-0.53, p=0.0002) in hypertensive patients. Conclusion Inhibition of the renin-angiotensin system, either with ACE inhibitors or AT 1 -receptor blockers improves endothelial dysfunction. ACE inhibition has prominent effects on improving insulin sensitivity and decreasing oxidative stress in essential hypertensive patients.
first_indexed 2024-03-07T18:57:38Z
format Article
id doaj.art-b508cc90d400455597039f00b7232dea
institution Directory Open Access Journal
issn 1470-3203
language English
last_indexed 2024-03-07T18:57:38Z
publishDate 2003-09-01
publisher SAGE Publications
record_format Article
series Journal of the Renin-Angiotensin-Aldosterone System
spelling doaj.art-b508cc90d400455597039f00b7232dea2024-03-02T00:08:17ZengSAGE PublicationsJournal of the Renin-Angiotensin-Aldosterone System1470-32032003-09-01410.3317/jraas.2003.032Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patientsDilek YavuzMehmet KoçAhmet ToprakIhsan AkpιnarAyliz VelioğluOguzhan DeyneliGoncagül HaklarSema AkallnObjective Disturbed endothelial function is closely associated with hyperinsulinaemia and insulin resistance in essential hypertension. The aims of this study were: 1) to evaluate whether the two alternative drugs, angiotensin-converting enzyme (ACE) inhibitors and Angiotensin II (Ang II) antagonists, had comparable effects on glucose metabolism and endothelial function. 2) to determine whether they improve endothelial dysfunction through modulating insulin resistance and oxidative stress. Study design and methods Study design and methods Essential hypertensive patients were randomised into two groups: Twelve (nine patients in final analysis) patients were given enalapril (enalapril group), and twelve (nine patients in final analysis) were given losartan (losartan group). Twelve sex- and age-matched normotensive volunteers were included as controls. Before and after six months of treatment, endothelial function, insulin sensitivity and lipid peroxidation (TBARs) and NO metabolites (NOx) were evaluated. Results Endothelial function, measured as flow mediated dilatation (FMD), was improved in both of the treatment groups (p=0.0001). Calculated insulin sensitivity index also improved in the enalapril-treated group (p=0.05) but not in the losartan-treated group, compared with baseline levels. TBARS values decreased significantly in the enalapril group compared with baseline levels (p<0.001). FMD was positively correlated with insulin sensitivity index (r=0.32, p<0.05) and NOx levels (r=0.39, p=0.01) and negatively correlated with TBARS levels (r=-0.53, p=0.0002) in hypertensive patients. Conclusion Inhibition of the renin-angiotensin system, either with ACE inhibitors or AT 1 -receptor blockers improves endothelial dysfunction. ACE inhibition has prominent effects on improving insulin sensitivity and decreasing oxidative stress in essential hypertensive patients.https://doi.org/10.3317/jraas.2003.032
spellingShingle Dilek Yavuz
Mehmet Koç
Ahmet Toprak
Ihsan Akpιnar
Ayliz Velioğlu
Oguzhan Deyneli
Goncagül Haklar
Sema Akalln
Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients
Journal of the Renin-Angiotensin-Aldosterone System
title Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients
title_full Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients
title_fullStr Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients
title_full_unstemmed Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients
title_short Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients
title_sort effects of ace inhibition and at1 receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients
url https://doi.org/10.3317/jraas.2003.032
work_keys_str_mv AT dilekyavuz effectsofaceinhibitionandat1receptorantagonismonendothelialfunctionandinsulinsensitivityinessentialhypertensivepatients
AT mehmetkoc effectsofaceinhibitionandat1receptorantagonismonendothelialfunctionandinsulinsensitivityinessentialhypertensivepatients
AT ahmettoprak effectsofaceinhibitionandat1receptorantagonismonendothelialfunctionandinsulinsensitivityinessentialhypertensivepatients
AT ihsanakpinar effectsofaceinhibitionandat1receptorantagonismonendothelialfunctionandinsulinsensitivityinessentialhypertensivepatients
AT aylizvelioglu effectsofaceinhibitionandat1receptorantagonismonendothelialfunctionandinsulinsensitivityinessentialhypertensivepatients
AT oguzhandeyneli effectsofaceinhibitionandat1receptorantagonismonendothelialfunctionandinsulinsensitivityinessentialhypertensivepatients
AT goncagulhaklar effectsofaceinhibitionandat1receptorantagonismonendothelialfunctionandinsulinsensitivityinessentialhypertensivepatients
AT semaakalln effectsofaceinhibitionandat1receptorantagonismonendothelialfunctionandinsulinsensitivityinessentialhypertensivepatients